Enrolling

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight…

The Transform trial is utilizing CCTA technology to develop a plaque staging software system for asymptomatic individuals at increased risk…

This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping…

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and chronic…

The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will…

The purpose of this study is to evaluate the efficacy of the medication JTT-861 administered for 12 weeks in subjects with heart failure…

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The…

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and…